Rivastigmine Patch, Extended Release
Product Images NDC 70771-1950

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Rivastigmine (NDC 70771-1950). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Zydus Lifesciences Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

4.6 mg/24 Hrs (Eb52b342 1672 42e7 Bb4c 9c8f1bce7fc3 01)

Packaging label for Rivastigmine Transdermal System 4.6 mg/24 hours by Zydus Lifesciences Limited. The label includes dosage form as an extended-release transdermal patch, container details with 30 systems per package, storage instructions, and manufacturer information. The design includes barcode and NDC 70771-1949-7.*

FDA Label Image

9.5 mg/24 Hrs (Eb52b342 1672 42e7 Bb4c 9c8f1bce7fc3 02)

Packaging label for Rivastigmine Transdermal System 9.5 mg/24 hours patch by Zydus Lifesciences Limited. The label includes dosage and administration instructions, manufacturer details, storage instructions, and a barcode. The carton indicates it contains 30 transdermal systems for prescription use.*

FDA Label Image

13.3 mg/24 Hrs (Eb52b342 1672 42e7 Bb4c 9c8f1bce7fc3 03)

Packaging label for Rivastigmine Transdermal System 13.3 mg/24 hours patch by Zydus Lifesciences Limited. The label shows the product name, dosage form (patch, extended release), strength, quantity (contains 30 systems), and directions to apply the patch for transdermal use only. It includes instructions for safe disposal and storage conditions. The label also features the NDC number 70771-1951-7 and is marked Rx only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.